NovoCure Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:038 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
03 May 25	Sell€9,352	Mukund Paravasthu	Individual	592	€15.80
03 Mar 25	Sell€4,415	Mukund Paravasthu	Individual	250	€17.66
03 Mar 25	Sell€36,255	Ashley Cordova	Individual	2,053	€17.66
03 Mar 25	Sell€4,831	Uri Weinberg	Individual	268	€18.03
03 Mar 25	Sell€44,626	Frank Leonard	Individual	2,527	€17.66
28 Feb 25	Sell€38,144	Mukund Paravasthu	Individual	2,014	€19.75
28 Feb 25	Sell€255,774	Ashley Cordova	Individual	13,494	€19.75
28 Feb 25	Sell€83,567	Uri Weinberg	Individual	4,637	€18.05
28 Feb 25	Sell€284,732	Frank Leonard	Individual	15,036	€19.75
27 Feb 25	Sell€19,070	Nicolas Leupin	Individual	991	€19.75
27 Feb 25	Sell€26,690	Michael Puri	Individual	1,387	€19.75
11 Jan 25	Sell€56,580	Mukund Paravasthu	Individual	2,160	€26.19
02 Nov 24	Sell€677	Mukund Paravasthu	Individual	44	€15.38
01 Nov 24	Sell€8,785	Frank Leonard	Individual	598	€14.69
01 Nov 24	Sell€2,342	Mukund Paravasthu	Individual	160	€14.64
31 Oct 24	Sell€11,781	Michael Puri	Individual	810	€14.54
02 Aug 24	Sell€12,689	Ashley Cordova	Individual	688	€18.44
04 Jun 24	Sell€21,162	Timothy Scannell	Individual	964	€21.95
04 Jun 24	Sell€21,160	Kinyip Leung	Individual	964	€21.95
04 Jun 24	Sell€21,167	William Vernon	Individual	964	€21.96

Insider Trading Volume

Insider Buying: 038 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 038?
Owner Type	Number of Shares	Ownership Percentage
General Public	4,978,427	4.47%
Individual Insiders	10,743,280	9.64%
Institutions	95,763,927	85.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 82.17% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.8%	FMR LLC	16,486,970	€262.8m	1.58%	0.02%
12.7%	Capital Research and Management Company	14,160,695	€225.8m	3.18%	0.01%
11.6%	BlackRock, Inc.	12,946,995	€206.4m	0.01%	no data
10.1%	The Vanguard Group, Inc.	11,251,497	€179.4m	-4.62%	no data
8.04%	Hansjoerg Wyss	8,967,046	€143.0m	10.1%	no data
4.95%	Soleus Capital Management, L.P.	5,521,414	€88.0m	102%	7.05%
2.32%	State Street Global Advisors, Inc.	2,588,716	€41.3m	-2%	no data
2.21%	Geode Capital Management, LLC	2,463,588	€39.3m	2.64%	no data
1.96%	UBS Asset Management AG	2,185,698	€34.8m	78.3%	no data
1.62%	Marshall Wace LLP	1,807,591	€28.8m	567%	0.05%
1.47%	Balyasny Asset Management L.P.	1,635,151	€26.1m	53%	0.07%
1.11%	Northern Trust Global Investments	1,235,439	€19.7m	-3.81%	no data
1.02%	Baillie Gifford & Co.	1,136,980	€18.1m	-2.1%	0.01%
0.9%	Palo Alto Investors LP	1,002,061	€16.0m	23.1%	3.68%
0.89%	Quantinno Capital Management LP	988,252	€15.8m	235%	0.11%
0.77%	Emerald Advisers, LLC	862,209	€13.7m	-1.21%	0.39%
0.73%	Charles Schwab Investment Management, Inc.	818,830	€13.1m	-2.08%	no data
0.73%	Goldman Sachs Group, Investment Banking and Securities Investments	814,890	€13.0m	2.08%	0.01%
0.69%	Renaissance Technologies LLC	768,654	€12.3m	4.67%	0.02%
0.65%	Voloridge Investment Management, LLC	725,966	€11.6m	-16.6%	0.05%
0.61%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	683,710	€10.9m	89.2%	no data
0.59%	Granite Investment Partners, LLC	653,331	€10.4m	-4.86%	0.57%
0.58%	Deerfield Management Company, L.P. Series C	650,119	€10.4m	0%	0.24%
0.56%	Frontier Capital Management Co LLC	625,898	€10.0m	-13.8%	0.11%
0.56%	C WorldWide Asset Management Fondsmaeglerselskab A/S	621,784	€9.9m	0%	0.09%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/23 10:46
End of Day Share Price	2025/05/23 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NovoCure Limited is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael King	Citizens JMP Securities, LLC
Gregory Gilbert	Deutsche Bank
Vijay Kumar	Evercore ISI